Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionVicus Capital
Latest Disclosed Ownership4,383 shares
Latest Disclosed Value $ 610,814
Vicus Capital reports 17.82% increase in ownership of GILD / Gilead Sciences, Inc.

On April 22, 2026 - Vicus Capital filed a 13F-HR form disclosing ownership of 4,383 shares of Gilead Sciences, Inc. (CH:GILD) valued at $610,814 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 3,720 shares of Gilead Sciences, Inc.. This represents a change in shares of 17.82% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-22 2026-03-31 13F GILEAD SCIENCES COM 375558103 4,383 663 17.82 611 33.77 0.0449
2026-01-22 2025-12-31 13F GILEAD SCIENCES COM 375558103 3,720 -66 -1.74 457 8.57 0.0342
2025-10-24 2025-09-30 13F GILEAD SCIENCES COM 375558103 3,786 52 1.39 420 1.69 0.0321
2025-07-18 2025-06-30 13F GILEAD SCIENCES COM 375558103 3,734 -671 -15.23 414 -16.23 0.0344
2025-04-17 2025-03-31 13F GILEAD SCIENCES COM 375558103 4,405 83 1.92 494 23.56 0.0460
2025-01-30 2024-12-31 13F GILEAD SCIENCES COM 375558103 4,322 -53 -1.21 399 9.02 0.0354
2024-10-21 2024-09-30 13F GILEAD SCIENCES COM 375558103 4,375 -1,431 -24.65 367 -8.04 0.0325
2024-07-23 2024-06-30 13F GILEAD SCIENCES COM 375558103 5,806 -505 -8.00 398 -13.85 0.0360
2024-04-17 2024-03-31 13F GILEAD SCIENCES COM 375558103 6,311 1,490 30.91 462 18.46 0.0421
2024-02-01 2023-12-31 13F GILEAD SCIENCES COM 375558103 4,821 -1,007 -17.28 391 -10.55 0.0395
2023-10-23 2023-09-30 13F GILEAD SCIENCES COM 375558103 5,828 720 14.10 437 10.94 0.0458
2023-08-17 2023-06-30 13F GILEAD SCIENCES COM 375558103 5,108 1,396 37.61 394 28.01 0.0410
2023-05-02 2023-03-31 13F GILEAD SCIENCES COM 375558103 3,712 -285 -7.13 308 -10.50 0.0331
2023-02-15 2022-12-31 13F GILEAD SCIENCES com 375558103 3,997 -192 -4.58 343 32.95 0.0389
2022-11-08 2022-09-30 13F GILEAD SCIENCES com 375558103 4,189 480 12.94 258 12.66 0.0304
2022-08-10 2022-06-30 13F GILEAD SCIENCES COM 375558103 3,709 231 6.64 229 10.63 0.0259
2022-05-11 2022-03-31 13F GILEAD SCIENCES COM 375558103 3,478 268 8.35 207 -1.43 0.0208
2022-02-10 2021-12-31 13F GILEAD SCIENCES COM 375558103 3,210 3,210 210 0.0214
2021-10-14 2021-09-30 13F GILEAD SCIENCES COM 375558103 0 -3,252 -100.00 0 -100.00
2021-08-10 2021-06-30 13F GILEAD SCIENCES COM 375558103 3,252 -338 -9.42 224 -3.45 0.0365
2021-05-04 2021-03-31 13F GILEAD SCIENCES com 375558103 3,590 3,590 232 0.0276
2021-02-01 2020-12-31 13F GILEAD SCIENCES COM 375558103 0 -4,819 -100.00 0 -100.00
2020-11-12 2020-09-30 13F GILEAD SCIENCES COM 375558103 4,819 -1,858 -27.83 305 -40.66 0.0433
2020-08-03 2020-06-30 13F GILEAD SCIENCES COM 375558103 6,677 1,003 17.68 514 21.23 0.0781
2020-05-07 2020-03-31 13F GILEAD SCIENCES com 375558103 5,674 -876 -13.37 424 -0.47 0.0791
2020-02-04 2019-12-31 13F GILEAD SCIENCES COM 375558103 6,550 -568 -7.98 426 -5.54 0.0646
2019-11-18 2019-09-30 13F GILEAD SCIENCES COM 375558103 7,118 -733 -9.34 451 -14.91 0.0628
2019-08-08 2019-06-30 13F GILEAD SCIENCES COM 375558103 7,851 -369 -4.49 530 -0.75 0.0744
2019-05-02 2019-03-31 13F GILEAD SCIENCES COM 375558103 8,220 351 4.46 534 8.54 0.0845
2019-02-07 2018-12-31 13F GILEAD SCIENCES COM 375558103 7,869 -67 -0.84 492 -19.74 0.0876
2018-11-13 2018-09-30 13F GILEAD SCIENCES COM 375558103 7,936 -64 -0.80 613 8.11 0.0985
2018-08-02 2018-06-30 13F GILEAD SCIENCES COM 375558103 8,000 -2,547 -24.15 567 -28.68 0.0934
2018-05-07 2018-03-31 13F GILEAD SCIENCES Com 375558103 10,547 -675 -6.01 795 -1.12 0.1375
2018-01-25 2017-12-31 13F GILEAD SCIENCES INC COM COM 375558103 11,222 -274 -2.38 804 -13.64 0.1402
2017-10-27 2017-09-30 13F GILEAD SCIENCES COM COM 375558103 11,496 2,751 31.46 931 50.40 0.1798
2017-07-21 2017-06-30 13F GILEAD SCIENCES COM COM 375558103 8,745 983 12.66 619 17.46 0.1265
2017-04-18 2017-03-31 13F GILEAD SCIENCES COM COM 375558103 7,762 1,321 20.51 527 14.32 0.1137
2017-01-24 2016-12-31 13F GILEAD SCIENCES INC COM COM 375558103 6,441 1,758 37.54 461 24.26 0.1027
2016-10-31 2016-09-30 13F GILEAD SCIENCES INC COM COM 375558103 4,683 748 19.01 371 13.11 0.0844
2016-08-02 2016-06-30 13F GILEAD SCIENCES INC COM COM 375558103 3,935 776 24.56 328 13.10 0.0795
2016-04-22 2016-03-31 13F GILEAD SCIENCES COM COM 375558103 3,159 891 39.29 290 26.64 0.0654
2016-01-13 2015-12-31 13F GILEAD SCIENCES COM Stock 375558103 2,268 2,268 229 0.0582
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.